Total mesorectal excision for rectal cancer--what can be achieved by a national audit?
about
Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancerCombination chemotherapy versus single agent chemotherapy during preoperative chemoradiation for resectable rectal cancerNeoadjuvant treatment for rectal cancer-A value-based proposition.Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgeryPrognostic value of lateral lymph node metastasis for advanced low rectal cancerRole of protective stoma in low anterior resection for rectal cancer: a meta-analysisParadigm shift in the management of rectal cancer.Multicentre prospective randomized trials are not always relevant to surgeons.Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma.Definition of total mesorectal excision, including the perineal phase: technical considerations.Total mesorectal excision and management of rectal cancer.Local recurrence after rectal cancer treatment in Manitoba.Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study.A novel risk-adjusted nomogram for rectal cancer surgery outcomes.Does total mesorectal excision require a learning curve? Analysis from the database of a single surgeon's experience.Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies.Tailored rectal cancer treatment--a time for implementing contemporary prognostic factors?MRI-based treatment of rectal cancer: is prognostication of the recurrence risk solid enough to render radiation redundant?Cancer staging in outcomes assessment.Current aspects and future prospects of total anorectal reconstruction--a critical and comprehensive review of the literature.Evaluating the addition of oxaliplatin to single agent fluoropyrimidine in the treatment of locally advanced rectal cancer: a systematic review and meta-analysis.Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer.Water soluble contrast enema examination of the integrity of the rectal anastomosis prior to loop ileostomy reversal may be superfluous.Reducing variation in surgical care.Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.Improved local control of rectal cancer reduces distant metastases.Improved guideline compliance after a 3-year audit of multidisciplinary colorectal cancer care in the western part of the Netherlands.Quality assessment of colorectal cancer care: an international online model.Utilisation of specialist care in patients with incurable rectal cancer. a population-based study from Western Norway.The Effect of Interval From Completion of Short-Course Radiotherapy to Surgery on the Post-Operative Morbidity and Mortality of Patients with Rectal Cancer.Can transanal tube placement after anterior resection for rectal carcinoma reduce anastomotic leakage rate? A single-institution prospective randomized studyDefunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trialSurvival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer
P2860
Q24186443-56E1C679-6F77-4CED-B540-BD2C62D7BC98Q24235103-884C1080-8E0A-4D5D-B676-01779D749E7DQ30251516-7F24EA8B-6359-4BA1-B047-D2BD333A1DF4Q34172017-32E31DD3-109B-4F9C-BA0B-7E02D9663FA2Q34606245-89BA9BD0-3E4A-4156-B435-BE486110425DQ34750854-F3C37B54-A6B3-4FB8-AAB1-46D344C65D2CQ34981092-D72AD6BA-7228-4F65-BF95-37D42780E46FQ36503773-ED178519-A467-447F-80C8-ACCB0E352C1FQ36540452-B11F1A14-3837-40A3-BED4-6A5DD05E7E68Q36614855-986E30D3-34E2-40EE-AF38-F1BC5A49C9B8Q36769796-E53AB22A-2E4F-415B-8836-3FC37C2616E7Q36974695-236A16B6-DD56-4131-B549-1FD0093FAEB5Q37088033-D2970944-8AAB-4576-9E0B-097569814212Q37350764-EAAC9C1D-8C78-4B90-BE73-1451F292FEFDQ37626835-E3EECDD6-6AFB-4C53-A3D4-2C62ADA55390Q37854498-15C6964F-DC0A-42E1-B818-8E3855916D00Q38001344-4662F044-1779-49F9-9A61-9F44F2E5878EQ38113863-3314188E-9DEE-4609-A81F-394C8BF908A3Q38134007-06DCA0F0-4B3E-435A-AC63-9B36B11592A6Q38231851-49611778-E64F-44EA-ABD4-B74ED5708D5BQ38268836-94678CC1-02AE-4A67-AD07-CDD1D9449DD7Q38618772-0876D21C-1C9E-4B5E-807F-29FCBE7F3922Q39767307-C391F5C0-1420-49CC-841B-ED3F866ECB80Q40250361-E05C86CC-408C-48A0-A08D-538EAEBFC510Q43063920-E8696252-A41C-49BB-A9C8-E5EFF6957A99Q43644545-5ACF057E-A18E-4864-B1EE-DD1CB784304EQ43914524-1C33906D-A776-411E-8E6A-55BAF2AEB23DQ44505004-00984632-921B-4359-8430-29F666CCFDA7Q45957646-F9D8CA38-571F-429E-8046-8819B6DADD7DQ50107749-88167589-5AB0-4D29-BEA3-DB85D0E2458BQ55284247-005D0594-D444-4B71-9B6D-1D2A2038E03AQ56777136-449EB94C-2CDC-4C7F-BD5D-26C43D5B21D8Q56785961-C11AF718-4191-42F1-B213-8A4B971291D1Q57258025-37FE7375-8299-45C3-A742-7F9FC856A2A6
P2860
Total mesorectal excision for rectal cancer--what can be achieved by a national audit?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Total mesorectal excision for rectal cancer--what can be achieved by a national audit?
@en
Total mesorectal excision for rectal cancer--what can be achieved by a national audit?
@nl
type
label
Total mesorectal excision for rectal cancer--what can be achieved by a national audit?
@en
Total mesorectal excision for rectal cancer--what can be achieved by a national audit?
@nl
prefLabel
Total mesorectal excision for rectal cancer--what can be achieved by a national audit?
@en
Total mesorectal excision for rectal cancer--what can be achieved by a national audit?
@nl
P2093
P1433
P1476
Total mesorectal excision for rectal cancer--what can be achieved by a national audit?
@en
P2093
H E Myrvold
Norwegian Rectal Cancer Group
P2860
P304
P356
10.1046/J.1463-1318.2003.00506.X
P577
2003-09-01T00:00:00Z